VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

9475	Companies
185441	Keywords
117777	Articles
99294	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 5 months ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 1 year 5 months ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
PRESS RELEASE

published on 06/06/2024 at 10:53, 1 year 5 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 1 year 5 months ago

Valbiotis and Nestlé Health Science terminate their licensing and supply agreement

Valbiotis Intellectual Property TOTUM•63 Food Supplements Nestlé
BRIEF

published on 06/04/2024 at 08:05, 1 year 6 months ago

Valbiotis and Nestlé Health Science terminate their licensing agreement

Diabetes Valbiotis Intellectual Property Dietary Supplement Nestlé Health Science
PRESS RELEASE

published on 06/04/2024 at 08:00, 1 year 6 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis terminates licensing and supply agreement with Nestlé Health Science, securing full ownership of TOTUM•63 for diabetes treatment. Strategic control and future partnerships planned

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 05/24/2024 at 17:45, 1 year 6 months ago

VALBIOTIS: Monthly information on voting rights and shares as of May 17, 2024

Share Capital Voting Rights Euronext Actions Valbiotis
BRIEF

published on 05/22/2024 at 17:45, 1 year 6 months ago

Valbiotis launches its e-commerce site for Valbiotis®PRO Cholesterol

E-commerce Valbiotis Lipidrive Hypercholesterolemia Food Supplements
PRESS RELEASE

published on 05/22/2024 at 17:40, 1 year 6 months ago

Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol
Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol on schedule, making innovative products accessible to all, including the Valbiotis®PLUS range of natural dietary supplements

Digital Marketing Valbiotis Dietary Supplements Valbiotis®PRO Cholestérol E-commerce Site
BRIEF

published on 05/14/2024 at 08:35, 1 year 6 months ago

Valbiotis publishes its voting rights figures for April 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 10 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 15 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 45 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 40 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 45 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:30, 15 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 30 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 5 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 15 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 40 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis

Les Echos

Published on 12/05/2025 at 08:45, 2 hours ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 45 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 1 minute ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE